NewCo News: Ligon Turns Microarray Screening Upside Down
By Catherine Shaffer
Thursday, December 9, 2010
Some potential protein drug targets, such as transcription factors, are difficult to study well in a high-density screening situation. Many transcription factors flop around like wet noodles with little organized structure, and are regarded as "undruggable" by many pharma companies.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.